News
Note from the MD: Markets remain in flux as recession fears grow
Rate hikes have been the talk of the town here at home and in the US. While the RBA’s recent 50bp hike pushed the Aussie cash rate to its highest level since 2015, its US counterpart took it up a few notches to 75bp, bringing the US federal funds rate target to its highest since 2008.
Wrap of the week: Supersized rate hike shocks global markets
Equity markets around the globe have bled after yet another supersized 75bps rate hike by the Fed, bringing the current US federal funds rate target up to 3%-3.25%, the highest since 2008, and blowing out 2023 projections to 4.6%.
Govt unveils next-gen shark detection system in Aussie hotspot
Great white sharks are swimming in increasing numbers along the WA coastline, as well as increasingly close to shore, so it’s little surprise the WA Government has again turned to an Aussie company to install solar-powered tagged-shark detection receivers in the region.
The cancer-fighting tech disabling ‘force fields’ around tumours
ASX-listed biotech Prescient Therapeutics has unveiled the second component of its CellPryme cell therapy enhancement platform on stage at the prestigious CAR-TCR Summit in Boston.
Very well positioned to benefit from structural change, says fundie
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In April, Yarra Capital Management’s Joel Fleming selected Probiotec as one of his favourite stocks, noting its potential for strong cash flow…
It has won many awards, and now Pepper has won over a veteran fundie too
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In May, Katana Asset Management’s Romano Sala Tenna selected Pepper Money as one of his favourite stocks, noting its first-rate management and…
Fundie’s strategy that saw his fund grow when indexes fell
If ever an investment group embodied the phrase ‘an oldie but a goodie’, it’s Hancock & Gore – from its roots as a blossoming sawmill business in 1867 to its market-outperforming status in modern times.
Note from the MD: Markets await rates call amid inflation panic
Global markets are on tenterhooks ahead of the release of the US Federal Open Market Committee’s latest interest rate decision, due early Thursday morning (Australian time).
Like it or not, this CEO paints a scarily real picture of our future
Investors are known for their interest in future tech and their appreciation of fine art – but would the love remain if these areas were combined? One enterprising CEO may have the answer.
Good as gold: Drilling begins at FEG’s highly prospective Woyla
Just over a week after the Indonesian Government granted its approval in a milestone decision, the first-ever drill rig to enter Woyla has been fired up and drilling has begun at the highly prospective copper-gold project.
Why an opportunity awaits first movers in budding S3 sector
The Australian pharma landscape is in for a notable change with the down-scheduling of low-dose cannabidiol (CBD) products to Schedule 3 (S3) or ‘pharmacist only medicine’ – and one health and wellness innovator’s proven capability to take brands to market ‘first and fast’ puts it in a unique position to be a pioneer in the industry.
Major weapons upgrade in the $1 trillion fight against cancer
There’s about a 50-50 chance you’ll get cancer at some point. Already the world’s second leading cause of death and of years of life lost, the global cancer burden is expected to grow 47% between 2020 and 2040, to about 29 million cases annually.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.